Cargando…
Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab
As we are over a year into the COVID-19 pandemic, we have made many forward strides in therapeutics. These treatments, such as monoclonal antibodies, have help mitigate the detrimental and often fatal consequences of COVID-19. The current indication for the use of monoclonal antibodies is mild to mo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336168/ https://www.ncbi.nlm.nih.gov/pubmed/34344651 http://dx.doi.org/10.1136/bcr-2021-243469 |